home / United States / Perspective Therapeutics

Perspective Therapeutics Market Cap

$0.14 B

+6.66 M

AMEX:CATX · April 20, 2025

Share price

$1.94

Enterprise Value

$-0.08 B

Change (1-Year)

-78.8%

Global Rank

#7293

Country Rank

#2826

Regions

USA

Market cap

As of April 20, 2025, Perspective Therapeutics (CATX) has a market cap of $0.14 billion USD. According to our data, Perspective Therapeutics is ranked No.7293 in global market value.

Sector Rank:

Biotech #473 Pharmaceuticals #432

CATX Market Capitalization Growth

1 Years Growth:

-78.8%

3 Years Growth:

-4.7%

5 Years Growth:

-45.1%

10 Years Growth:

-78.7%

15 Years Growth:

-74.5%

20 Years Growth:

-93.6%

Total Growth:

-93%

Perspective Therapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Perspective Therapeutics Market Cap CAGR Chart

Perspective Therapeutics Market Cap History 2005 - 2025

Year	Market Cap	%Change
Apr 20, 2025	$0.14 B	-33.37%
Dec 31, 2024	$0.22 B	-20.25%
Dec 29, 2023	$0.27 B	60.00%
Dec 30, 2022	$0.17 B	-35.90%
Dec 31, 2021	$0.26 B	-13.33%
Dec 31, 2020	$0.30 B	-27.42%
Dec 31, 2019	$0.42 B	106.67%
Dec 31, 2018	$0.20 B	-25.00%
Dec 29, 2017	$0.27 B	-31.03%
Dec 30, 2016	$0.39 B	-38.30%
Dec 31, 2015	$0.64 B	-35.62%
Dec 31, 2014	$0.99 B	192.00%
Dec 31, 2013	$0.34 B	-35.90%
Dec 31, 2012	$0.53 B	18.18%
Dec 30, 2011	$0.45 B	-41.59%
Dec 31, 2010	$0.76 B	26.97%
Dec 31, 2009	$0.60 B	345.00%
Dec 31, 2008	$0.14 B	-90.05%
Dec 31, 2007	$1.36 B	-58.98%
Dec 29, 2006	$3.31 B	-32.41%
Dec 30, 2005	$4.90 B	100%

Similar Companies to Perspective Therapeutics

Name	Market Cap	Market cap difference	Regions
Novartis NVS	$219.89 B	0.932 B	Switzerland
Pfizer PFE	$125.57 B	0.001 M	USA
Merck MRK	$196.28 B	0.008 M	USA
Johnson & Johnson JNJ	$379.48 B	-0.003 M	USA
Amgen AMGN	$149.09 B	0.124 B	USA
Gilead Sciences GILD	$130.32 B	-0.001 M	USA
Bristol-Myers Squibb BMY	$100.17 B	-0.004 M	USA
AbbVie ABBV	$306.02 B	0.008 M	USA
Eli Lilly LLY	$754.27 B	0.008 M	USA
Biogen BIIB	$17.36 B	-0.001 M	USA
Regeneron Pharmaceuticals REGN	$61.57 B	1.023 B	USA
Sanofi SNY	$124.64 B	0.327 B	France
AstraZeneca AZN	$210.29 B	0.735 B	UK
GlaxoSmithKline GSK	$72.79 B	-0.000 M	UK

About Perspective Therapeutics Inc.

Name

Perspective Therapeutics, Inc.

Website

https://www.perspectivetherapeutics.com

Headquarters

Seattle,WA

symbol

CATX

CURRENCY

USD

country

United States

fullTimeEmployees

138

exchange

ASE

firstTradeDateEpochUtc

1969/12/31

CATX Market Cap Formula

Market Cap	=	CATX Stock Price	*	CATX Shares Outstanding
	=	$1.94	*	74.05 M
	=	$0.14 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe